Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis

D Fang, B Chen, A Lescoat, D Khanna… - Nature Reviews …, 2022 - nature.com
Systemic sclerosis (SSc) is a destructive connective tissue disease characterized by
dysregulation of the immune system and fibrosis in the skin and internal organs. The …

[HTML][HTML] Current and emerging strategies to inhibit type 2 inflammation in atopic dermatitis

EB Haddad, SL Cyr, K Arima, RA McDonald… - Dermatology and …, 2022 - Springer
Type 2 immunity evolved to combat helminth infections by orchestrating a combined
protective response of innate and adaptive immune cells and promotion of parasitic worm …

[HTML][HTML] Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis

F Ma, O Plazyo, AC Billi, LC Tsoi, X Xing… - Nature …, 2023 - nature.com
The immunopathogenesis of psoriasis, a common chronic inflammatory disease of the skin,
is incompletely understood. Here we demonstrate, using a combination of single cell and …

[HTML][HTML] Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis

M Rudnik, A Hukara, I Kocherova, S Jordan… - Frontiers in …, 2021 - frontiersin.org
Background Systemic sclerosis (SSc) is an autoimmune disease characterized by
overproduction of extracellular matrix (ECM) and multiorgan fibrosis. Animal studies pointed …

Molecular features and stages of pulmonary fibrosis driven by type 2 inflammation

H Mattoo, DS Bangari, S Cummings… - American Journal of …, 2023 - atsjournals.org
Systemic sclerosis (SSc) is a progressive, multiorgan disease with limited treatment options.
Although a recent proof-of-concept study using romilkimab or SAR156597, a bispecific IL …

B cell depletion inhibits fibrosis via suppression of profibrotic macrophage differentiation in a mouse model of systemic sclerosis

H Numajiri, A Kuzumi, T Fukasawa… - Arthritis & …, 2021 - Wiley Online Library
Objective We undertook this study to investigate the effect of B cell depletion on fibrosis in
systemic sclerosis (SSc) and its mechanism of action. Methods Mice with bleomycin …

Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis

R Bhandari, H Yang, NN Kosarek, AE Smith… - …, 2023 - academic.oup.com
Objectives Prior work demonstrates that co-cultured macrophages and fibroblasts from
patients with SSc engage in reciprocal activation. However, the mechanism by which these …

Patients with systemic sclerosis show phenotypic and functional defects in neutrophils

D Impellizzieri, C Egholm, A Valaperti, O Distler… - Allergy, 2022 - Wiley Online Library
Abstract Background Systemic sclerosis (SSc) is a multiorgan autoimmune disease
characterized by inflammation, vascular modification, and progressive fibrosis of the skin …

Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?

R Russo, E Cozzani, G Gasparini… - Dermatologic …, 2020 - Wiley Online Library
Bullous pemphigoid, mucous membrane pemphigoid, and pemphigus vulgaris are different
cutaneous autoimmune blistering diseases, with complex pathogenic mechanisms. In all of …

[HTML][HTML] Human regulatory T cells: understanding the role of tregs in select autoimmune skin diseases and post-transplant nonmelanoma skin cancers

NC Oparaugo, K Ouyang, NPN Nguyen… - International journal of …, 2023 - mdpi.com
Regulatory T cells (Tregs) play an important role in maintaining immune tolerance and
homeostasis by modulating how the immune system is activated. Several studies have …